This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignees: Tufts University, University of Houston System. Active years: 2021.
Company Filing History:
1 out of 655 
1 out of 618 
Years Active: 2021
Title: Chalada Suebsuwong: Innovator in Protein Kinase Inhibition
Introduction
Chalada Suebsuwong is a notable inventor based in Houston, Texas, recognized for his contributions to the field of biochemistry. He holds a patent that focuses on compositions and methods for inhibiting protein kinases, which are crucial in various cellular processes.
Latest Patents
Suebsuwong's patent, titled "Compositions and methods for inhibiting protein kinases," identifies compounds that demonstrate protein kinase inhibitory activity. These compounds inhibit dependent cell signaling pathways, such as NOD2 cell signaling. More specifically, the compounds are shown to inhibit receptor interacting kinase 2 (RIPK2) and/or Activin-like kinase 2 (ALK2). The development of dual RIPK2/ALK2 inhibitors or those that preferentially inhibit either RIPK2 or ALK2 could provide significant therapeutic benefits.
Career Highlights
Throughout his career, Chalada Suebsuwong has worked with esteemed institutions, including the University of Houston System and Tufts College. His work has contributed to advancements in understanding protein kinases and their role in cellular signaling.
Collaborations
Some of his notable coworkers include Gregory D. Cuny and Alexei Degterev, who have collaborated with him on various research projects.
Conclusion
Chalada Suebsuwong's innovative work in protein kinase inhibition highlights the potential for therapeutic advancements in treating diseases linked to cell signaling pathways. His contributions to the field continue to pave the way for future research and development.